DISEASE SCANNER
Global Incurable Diseases Tracker
Vaginal Atrophy (Genitourinary Syndrome of Menopause)
Thinning, drying, and inflammation of the vaginal walls due to decreased estrogen levels, typically occurring after menopause. Affects urinary and sexual function.
45.0M
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Pelvic examination
- 2Vaginal pH testing (elevated >5)
- 3Wet mount microscopy
- 4Hormone level testing
- 5Biopsy (if atypical findings)
Prognosis
Excellent with treatment. Symptoms improve in 80-90% of women within 3-4 weeks of vaginal estrogen. Moisturizers provide ongoing relief. Treatment can be continued long-term safely. Laser therapy provides 12+ months improvement. Quality of life and sexual function significantly improve. No cure without estrogen restoration.
Prevention
- Regular sexual activity (promotes blood flow)
- Smoking cessation
- Vaginal moisturizers before symptoms severe
- Hormone therapy consideration at menopause
Research Status
Vaginal estrogen therapy (creams, tablets, rings), vaginal moisturizers and lubricants, oral ospemifene (SERM), laser therapy (vaginal rejuvenation), and systemic hormone therapy.
Affected Countries
Sources
- https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2013/12/treatment-of-menopause-associated-vasomotor-symptoms
- https://www.menopause.org/publications/clinical-care-recommendations
- https://www.mayoclinic.org/diseases-conditions/vaginal-atrophy
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.